Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir. - Wikidata - wikimedia - TriplyDB

Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir.

Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir.

http://www.wikidata.org/entity/Q38223361

about

Efficacy of tenofovir disoproxil fumarate therapy in nucleoside-analogue naive Iranian patients treated for chronic hepatitis B.Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis.Efficacy of entecavir and tenofovir in chronic hepatitis B under treatment in the public health system in southern Brazil.Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B Adverse effects of oral antiviral therapy in chronic hepatitis B.A meta-analysis comparing the efficacy of entecavir and tenofovir for the treatment of chronic hepatitis B infection.Pharmacotherapeutic options for hepatitis B.Week 4 viral load predicts long-term suppression of hepatitis B virus DNA during antiviral therapy: improving hepatitis B treatment in the real world.Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues.Identification of a novel human circulating metabolite of tenofovir disoproxil fumarate with LC-MS/MS.

P2860

Q35671645-163414C2-F3FB-4152-8A94-0A9F1F7A8026 Q35819595-297BAA6E-EB83-4E22-852E-983E800803E1 Q36793870-65AC62B0-C756-4CF0-B279-897D5AF8DE9E Q37381790-13A7E36B-7108-462E-99AA-154BB7916366 Q37651892-48DBACE8-F94B-4692-89F4-BB7C37C32DD9 Q38257890-FB9EF730-4E0F-43F3-8D8D-D46A64E01AE4 Q38631076-070B9089-399B-47E9-8B9D-E61E7AABD2E5 Q39443390-1AF42B4B-6D1F-452A-9F94-C2C58C1662C7 Q40934257-9F4AEC75-0F5F-4F04-B8DF-C7BE2F9F99C0 Q41284684-750BE5DC-FFF2-489A-B86D-89F8B0DB97F2 Q41336340-F7A042CD-BC87-4EC6-8DE6-0DF9B258894E

P2860

Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir.

http://www.wikidata.org/entity/Q38223361

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir.

@en

type

label

Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir.

@en

prefLabel

Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir.

@en

P1433

Q38223361-4B46F82E-DBE1-4E3C-B164-6A9576BC757A

P1476

Q38223361-38EA77D8-42DE-4B8F-97F1-C72F0828CFFF

P2093

Q38223361-36A649CD-2037-4310-A823-2372A05608CF

P2860

Q38223361-013E4C7C-AE32-4314-95E5-69AD9696DF21

Q38223361-03F13F4B-FF3B-4329-A3F4-66AF10826120

Q38223361-114AE77A-9E7F-4924-BE25-D4513F1E4B06

Q38223361-11C9A1AD-D424-4A1D-8B9B-A65D9EB302FC

Q38223361-3426A50C-E1A7-4FE5-BD23-ED01E8A78538

Q38223361-36626C1A-63F7-4A05-AE71-20991EA1A6E8

Q38223361-36C6486D-251D-48F1-A88B-C264C9021674

Q38223361-475C967F-F201-436F-B68F-0608201C22F7

Q38223361-5B095E22-E57D-4C5B-A9EE-53A42FF577FD

Q38223361-5D4A5732-5F35-4DF9-B7D7-B65A7B3C07E4

P304

Q38223361-71A115E5-83BA-436E-B536-E186341239ED

P31

Q38223361-867E7901-9606-4852-853E-C69B4FD9BF75

P356

Q38223361-95056D3E-7BB9-4D46-AD05-0DC0A5E32709

P407

Q38223361-AD6B1EBC-C7A6-4F9B-B5E5-71BD8E4B9E3C

P433

Q38223361-7E5D7396-B5B2-4841-9342-2DDD6EC2E70A

P478

Q38223361-9724388F-4A42-4F6B-BC97-512FDB2A6956

P50

Q38223361-22809743-1C5E-4746-99CB-82E0915E8EBF

P577

Q38223361-6E24CBC4-0CAD-472D-B528-48B98FA4914D

P5875

Q38223361-20DDCC12-7D67-4E0B-A5D9-5BD9AE0BB46C

P698

Q38223361-6025120A-20A8-4336-A1CD-A728457EEDF2

P932

Q38223361-03044674-ACF8-4A13-A44B-DB6CCA55F7C7

P356

WJG.V20.I23.7169

P1433

World Journal of Gastroenterology

P1476

Treatment of chronic hepatitis B in clinical practice with entecavir or tenofovir

@en

P2093

Ezequiel Ridruejo

http://www.w3.org/2001/XMLSchema#string

P2860

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Chronic hepatitis B: update 2009

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

Effectiveness of hepatitis B treatment in clinical practice.

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

Clinical and virological response to entecavir in HBV-related chronic hepatitis or cirrhosis: data from the clinical practice in a single-centre cohort.

Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.

Australian tertiary care outcomes of entecavir monotherapy in treatment naive patients with chronic hepatitis B

Efficacy of entecavir treatment for up to 5 years in nucleos(t)ide-naïve chronic hepatitis B patients in real life.

P304

7169-7180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I23.7169

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263476148

http://www.w3.org/2001/XMLSchema#string

P698

24966587

http://www.w3.org/2001/XMLSchema#string

P932

4064062

http://www.w3.org/2001/XMLSchema#string